Podcast Episodes
Back to Search
Evolving Therapy for Myeloma: Experts Discuss Patient Case Examples
Episode 111
In this episode,Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discuss t…
4 years, 4 months ago
Expert Insights on Advances in Immune Thrombocytopenia
Episode 110
In this episode, Keith R. McCrae, MD; Nichola Cooper, MD; and Rachael Grace, MD, MMSc,provide expert insights on immune thrombocytopenia management, …
4 years, 4 months ago
Precision Medicine for aTTP: Expert Answers to Your Questions
Episode 109
In this episode, Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshal Mazepa, MD, answer questions from an audience of healthcare professionals on topic…
4 years, 5 months ago
Precision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions
Episode 108
In this episode, Steven M. Horwitz, MD; Francine Foss, MD; and Barbara Pro, MD, answer questions from an audience of healthcare professionals on topi…
4 years, 5 months ago
Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease
Episode 107
In this podcast episode, Conor Ernst Steuer, MD, a medical oncologist; Frank Schneider, MD, a pathologist; and Elise Hitron, MSN, FNP-C, a phase I cl…
4 years, 5 months ago
Experts Answer Questions on Current and Emerging Options for Hemophilia A Management
Episode 106
In this podcast episode, 3 experts answers questions on the management of hemophilia A from a live webinar. Topics include:
Which patients should hav…4 years, 5 months ago
Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations
Episode 103
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses targeted therapy with FLT3 and IDH1/2 inhibitors in AML, with a focus on the nu…
4 years, 5 months ago
Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
Episode 104
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable m…
4 years, 5 months ago
Strategies for Secondary AML and Emerging Therapies for AML
Episode 105
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinic…
4 years, 5 months ago
An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy
Episode 102
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses acute myeloid leukemia and management approaches for patients unfit for in…
4 years, 5 months ago